Person

James M. Kilts

Director, Viatris

Current S&P 500 boards
1
Current roles
1
Open-market buys
$1.5M
Open-market sales
$0

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

  • PFE
    Pfizer
    Director
    2016 or earlier – last filing Sep 2020
  • MET
    MetLife
    Director
    2016 or earlier – last filing Jun 2020

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Dec 16, 2020VTRSBuy27,736$17.66$490K
Mar 22, 2017METBuy17,205$51.13$880K
Mar 1, 2017METBuy2,795$54.17$151K

SEC reporting-owner ID (CIK) 1025094 · all filings on EDGAR

James M. Kilts (VTRS) | USBoard